Stryker Corporation (SYK): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Stryker Corporation ( SYK) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 1.3%. By the end of trading, Stryker Corporation fell 55 cents (-1%) to $54.05 on average volume. Throughout the day, 2.5 million shares of Stryker Corporation exchanged hands as compared to its average daily volume of 2.1 million shares. The stock ranged in price between $53.86-$55.08 after having opened the day at $54.82 as compared to the previous trading day's close of $54.60. Other companies within the Health Services industry that declined today were: Theragenics Corporation ( TGX), down 5.2%, Celsion Corporation ( CLSN), down 4.5%, AdCare Health Systems ( ADK), down 3.4%, and IsoRay ( ISR), down 3.3%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $20.61 billion and is part of the health care sector. The company has a P/E ratio of 14.6, below the S&P 500 P/E ratio of 17.7. Shares are up 9.1% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Stryker Corporation a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front, CombiMatrix Corporation ( CBMX), up 12.2%, Response Genetics ( RGDX), up 11.8%, Spherix ( SPEX), up 11.5%, and NeuroMetrix ( NUROD), up 8.3%, were all gainers within the health services industry with Covidien ( COV) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers